News

The Center for NanoMedicine News

UT Health Science Center at Houston, UT M.D. Anderson Break Ground on New Imaging Research Facility — by Matthew Landry — last modified 2007-04-10 19:48

HOUSTON—(April 10, 2007)—Ground was broken today at The University of Texas Research Park for a joint research facility dedicated to developing novel agents and imaging technologies that detect heart disease, cancer and other illnesses at their earliest – and most treatable or preventable – stages.

New Imaging Research Facility Dedicated to Detection of Early Stage Disease — by Matthew Landry — last modified 2007-06-06 15:49

Ground was broken April 10 at The University of Texas Research Park in Houston for a joint research facility dedicated to developing novel agents and imaging technologies that detect heart disease, cancer and other illnesses at their earliest – and most treatable or preventable – stages.

NanoEthics: The Risks and Benefits of Nanotechnology — by Matthew Landry — last modified 2007-07-19 09:44

Think of the smallest thing you can imagine: the thin edge of a piece of paper, the width of a human hair, or, if you've ever used a microscope, the diameter of a red blood cell. A new area of scientific research deals with understanding and controlling materials thousands of times smaller than these things. It is called nanotechnology.

Ferrari Addresses President’s Council on Bioethics — by Matthew Landry — last modified 2007-08-27 12:56

Mauro Ferrari, Ph.D., director of the Research Center for NanoMedicine at The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM), a part of The University of Texas Health Science Center at Houston, discussed nanotechnology and nanomedicine before a meeting of the President’s Council on Bioethics.

Cancer nanotechnology: small, but heading for the big time — by Matthew Landry — last modified 2007-11-26 10:35

With cancer at the forefront of therapeutic applications of nanotechnology, Dan Jones investigates progress in the field.

Mathematical engines of nanomedicine — by Matthew Landry — last modified 2008-02-27 10:09

(Nanowerk Spotlight) The process of bringing a major new drug to market, from discovery to marketing, takes about 10-12 years and costs an average of $500-$800 million in industrialized countries.

Nanomedicine System Engineered To Enhance Therapeutic Effects of Injectable Drugs — by Matthew Landry — last modified 2008-03-03 10:49

HOUSTON—(March 2, 2008)—In an article featured on the cover of the March issue of “Nature Nanotechnology,” Mauro Ferrari, Ph.D., of The University of Texas Health Science Center at Houston presented a proof-of-concept study on a new multistage delivery system (MDS) for imaging and therapeutic applications. This discovery could go a long way toward making injectable drugs more effective. The study is included in the March 2 Advance Online Publication on “Nature Nanotechnology’s”.

Targeted Delivery for Nanoparticles — by Matthew Landry — last modified 2008-04-10 10:53

Microcontainers could improve cancer treatment by carrying nanoparticles directly to tumors. By Kevin Bullis